T he implantable cardioverter-defibrillator (ICD) prevents sudden cardiac death in patients with a history of sudden cardiac arrest and in patients with heart failure and reduced ejection fraction. [1] [2] [3] [4] Since the widespread adoption of ICD therapy for primary prevention, the number of patients with ICDs has risen substantially with nearly 150 000 new implants in 2009 alone (the most recent data available). 5 Device infection remains a common reason for system revision and one that usually necessitates system explantation, 6, 7 but when lead replacement is indicated for other reasons (eg, lead fracture), there are 2 potential approaches to managing the existing lead: explantation or abandonment. To date, data comparing management strategies of unused or malfunctioning ICD leads have been limited to single-center studies some of which examined lead explantation and lead abandonment in isolation, [8] [9] [10] [11] whereas others compared these strategies to one another. [12] [13] [14] [15] Thus, in the absence of a large, multicenter comparison of real-world outcomes, the relative risks and benefits of each approach remain unclear.
Using data from the National Cardiovascular Data Registry (NCDR) ICD Registry (the Registry) and the Centers for Medicare and Medicaid Services, we conducted a study to compare characteristics of patients, providers, and facilities associated with abandonment or explantation of an unused or malfunctioning ICD lead and examine both acute and longerterm outcomes associated with these different management strategies. Outcomes in Lead Abandonment Versus Explantation
Methods

Data Sources
Data for this investigation were acquired from 2 sources: the NCDR ICD Registry and the Centers for Medicare and Medicaid Services. The NCDR ICD Registry has been described previously. 16 Briefly, it was launched in 2005 by the American College of Cardiology and the Heart Rhythm Society to meet a Centers for Medicare and Medicaid Services mandate requiring data submission on all Medicare beneficiaries receiving a primary prevention ICD. Since launching of this Registry, a large majority of participating hospitals submit data on all ICD implants. In 2010, a leads only data collection form was added to capture characteristics of ICD procedures not involving generator placement or replacement. Registry data are submitted via a secure Website and are subject to rigorous electronic quality checks. Although there is significant variability between data elements, formal auditing of data entered into the Registry demonstrated overall raw data accuracy of 91.2%. 17 Medicare data include inpatient and outpatient claims and the corresponding denominator files for 2010 through 2011. We linked the Registry data to Medicare claims using a combination of indirect identifiers including age, sex, admission date, procedure date, and hospital identification for the examination of postprocedure survival and complications.
Study Population
To study procedural complications, we included all patient encounters involving either defibrillator lead abandonment or explantation in the NCDR ICD Registry from April 2010 to June 2011 (n=43 232; Figure 1 ). We use the term explantation rather than extraction because we were not able to exclude procedures involving simple traction techniques versus true extraction. Many pace-sense lead procedures are also captured in the Registry, so all lead models had to be characterized manually as a transvenous pacing only lead versus a transvenous defibrillator lead versus other (eg, epicardial and coronary sinus) to capture abandonment or explantation of transvenous defibrillator leads only. Procedures were assigned to the lead abandonment versus explantation groups based on the management of the defibrillator lead regardless of whether any other leads were involved in the procedure. Patient encounters were excluded if they involved a procedure that included both abandonment and explantation (n=143) or if there was
WHAT IS KNOWN
• Patients with an unused/malfunctioning implantable cardioverter defibrillator (ICD) lead undergoing revision may have the unused/malfunctioning lead either abandoned or explanted.
• ICD leads are revised based on weighing upfront risks of explantation against later risks of lead abandonment, but comparative safety data between these two revision strategies are limited.
WHAT THE STUDY ADDS
• Compared with lead abandonment, patients undergoing lead explantation of an unused/ malfunctioning ICD lead had slightly higher in-hospital complications and deaths.
• One year after lead revision in a Medicare population, mortality risk was higher in lead the explantation patients compared with abandonment patients, but the difference did not meet statistical significance. evidence of definite or presumed ICD infection because this would generally be an indication for system explantation (n=4259). Patient encounters with the procedure performed by a cardiothoracic surgeon were excluded (n=1990) because it was assumed that lead explantation was predetermined in these cases. This resulted in an analysis cohort of 36 840 patient encounters in 1241 facilities.
To study postprocedure survival, we limited our analysis to those patients who could be matched to Medicare enrollment files that include postdischarge information on all fee-for-service Medicare beneficiaries aged ≥65 years. Patient data in the Registry were merged with Medicare Part A inpatient claims, matching by patients' age, admission date or procedure date, sex, and hospital. As a result, we identified 1985 patient encounters from 1980 patients who were Medicare eligible at any time during follow-up for a survival analysis.
Finally, to evaluate complications ≤6 months post discharge, we excluded 201 patient encounters from the Medicare cohort in which the patient was not insured by Medicare either at the time of the procedure or over the course of the 6-month follow-up because we could not confirm capture of complications without this consistency in Medicare insurance. This analysis included 1784 patient encounters in 1780 unique Medicare patients.
Outcomes
The primary outcome for this analysis was in-hospital procedurerelated complications or death from the NCDR ICD Registry from April 2010 through June 2014. Each outcome was examined individually and by severity (major versus minor) as has been done previously. 18 Secondary outcomes for Medicare patients included (1) all-cause mortality at discharge, 90 days, and 1 year; patients with no record of death in the denominator file were considered alive as of May 3, 2012 or the date at which the patient was no longer enrolled in Part A and Part B fee-for-service Medicare, whichever came first and (2) incidence of bleeding, tamponade, infection, need for urgent surgery, upper extremity thrombosis, and pulmonary embolism at 6 months as determined by relevant International Classification of Diseases Ninth Revision codes (Data Supplement). Six-month complication outcomes were chosen to reflect the period of time during which a complication could reasonably be attributed to the abandonment or explantation procedure.
Statistical Analysis
We compared baseline characteristics between the lead abandonment and lead explantation groups. Most baseline characteristics were available directly from the Registry; however, the number of high-voltage coils on the defibrillator lead undergoing revision is not included in the Registry, but this characteristic has been established as critical. Accordingly, for each lead model recorded in the data set, coil number was determined manually through a combination of searching manufacturer Websites and catalogs, and, when necessary, through direct telephone contact with manufacturer customer support. Continuous variables were compared using T tests, and categorical variables were compared with the χ 2 test. Summaries of these descriptive analyses are reported as percentages for categorical variables and as means and SDs for continuous variables. The standardized difference for each variable, defined as the absolute difference in means (or proportions) divided by the average SD, is also reported for each variable.
In-hospital death, in-hospital procedural complications, and in-hospital death or procedure events were compared between unmatched groups using logistic regression models. Categories of independent variables were added into the model in the following order: none, medical history, procedural characteristics, hospital characteristics, and operator characteristics.
Significant and important differences between the lead abandonment and explantation patients were expected in this nonrandomized cohort. A preliminary examination of the data confirmed this. As such, a 1:1 matched-patient analysis was planned and performed according to the methods described by Rosenbaum and Rubin. 19 Briefly, a propensity model was built using logistic regression in which the dependent variable was an indicator of whether each patient was from the abandonment or explantation group, and the independent variables were baseline variables regarded as potentially clinically important. Independent variables included those listed in 1 and 2. Of note, because we could not differentiate implant duration for the lead being revised from other indwelling leads, we included the maximum lead implant duration in our model. Missing values for the covariates were rare (<2%) except for ICD indication (24%) and final device type (24%), so these were imputed to the most common values for categorical variables and to the median for continuous variables in the model analyses. In addition, for the ICD indication and the final device type variables, dummy variables indicating the presence of a missing value were added into the model.
The number of patients in the lead abandonment group was larger than the lead explantation group, so patients were selected from the lead abandonment group to match those in the lead explantation group in a 1:1 ratio based on the propensity models. An estimated probability of being an explantation patient (propensity score) and a corresponding logit (log e [p/(1−p)]) was calculated for each patient. For a given explantation patient, all abandonment patients were considered whose logit differed from the explantation patient's logit by less than the caliper width (0.6×SD of the logit); among these patients, the abandonment patient with the closest logit from the explantation patient was selected as the match. Each abandonment patient was matched at most once for each analysis. Differences in procedural complications between the matched groups of patients were assessed using the χ 2 test.
The matching process was repeated for the Medicare subgroup to obtain matched groups for a comparison of device-related complications at 6 months as well as mortality predischarge, 90 days, and 1 year. Unadjusted all-cause mortality event rates were summarized with Kaplan-Meier survival curves. Six-month complications were compared between groups using the χ 2 statistic for categorical variables. Results were considered statistically significant when 2-sided P value is <0.05. All analyses were performed with SAS version 9.3 (SAS Institute, Cary, NC).
Results
Baseline Characteristics
Baseline characteristics for the overall lead abandonment and explantation cohorts before and after matching are listed in Tables 1 and 2 . The Medicare 6-month complications cohort was similar to the Medicare survival cohort (Data Supplement). Before matching in the NCDR cohort, there were 36 840 patient encounters including 20 918 and 15 922 in the abandonment and explantation groups, respectively. Before matching in the Medicare cohort, there were 1985 total patient encounters for the survival analysis (1239 abandonment and 746 explantation) and 1784 patient encounters for the 6-month complications analysis (1121 abandonment and 663 explantation).
In all 3 of the analysis cohorts, compared with patients in the explantation group, those in the abandonment group were older, had a greater burden of comorbid conditions, were more likely to have a primary prevention ICD, and were treated at hospitals with less experience in lead explantation; facility and provider characteristics were similar for patients in the explantation and abandonment groups. Maximum lead implant duration was significantly longer in the abandonment group (6.5 versus 5.0 years in the overall cohort, 5.5 versus 4.1 years in the Medicare survival cohort, and 5.4 versus 4.1 years in the Medicare 6-month complications cohort). Severity of heart failure as measured by New York Heart Association functional class and rates of important comorbidities including history of coronary artery bypass grafting surgery, lung disease, and diabetes mellitus were similar between groups. Other baseline characteristics used in the propensity model included: history of syncope, family history of sudden death, previous myocardial infarction, previous percutaneous coronary intervention, electrophysiology study, QRS duration, systolic blood pressure, diastolic blood pressure, BUN (blood urea nitrogen; mean), potassium (mean), procedure type (initial generator vs generator change vs lead only), coumadin held for procedure, final device type (single chamber vs dual chamber vs cardiac resynchronization therapy), number of leads in the procedure, discharge medications (angiotensin converter enzyme inhibitor, angiotensin receptor blocker, aspirin, β-blocker, diuretic, and warfarin), hospital ownership (public vs private vs not-for-profit), hospital setting (division, micro, metro, and rural), number of staffed hospital beds, hospital teaching status, ability to perform advanced cardiac procedures, and hospital geographic region. ASD indicates absolute standardized difference; CABG, coronary artery bypass grafting; ICD, implantable cardioverter-defibrillator; LVEF, left ventricular ejection fraction; NCDR, National Cardiovascular Data Registry; and NYHA, New York Heart Association.
*ASD defined as the absolute difference in means (or proportions) divided by the average SD. †NYHA categories do not add up to total because of some missingness. ‡When >1 lead was present, the maximum lead implant duration was used. §These groups are not mutually exclusive. Many subjects in this cohort had >1 indwelling ICD lead and the presence of any single-coil or dual-coil lead is reported here. Other baseline characteristics used in the propensity model included: history of syncope, family history of sudden death, previous myocardial infarction, previous percutaneous coronary intervention, electrophysiology study, QRS duration, systolic blood pressure, diastolic blood pressure, BUN (blood urea nitrogen; mean), potassium (mean), procedure type (initial generator vs generator change vs lead only), coumadin held for procedure, final device type (single chamber vs dual chamber vs cardiac resynchronization therapy), number of leads in the procedure, discharge medications (angiotensin converter enzyme inhibitor, angiotensin receptor blocker, aspirin, β-blocker, diuretic, and warfarin), hospital ownership (public vs private vs not-for-profit), hospital setting (division, micro, metro, and rural), number of staffed hospital beds, hospital teaching status, ability to perform advanced cardiac procedures, and hospital geographic region. ASD indicates absolute standardized difference; CABG, coronary artery bypass grafting; LVEF, left ventricular ejection fraction; and NYHA, New York Heart Association.
*ASD defined as the absolute difference in means (or proportions) divided by the average SD. †NYHA categories do not add up to total because of some missingness. ‡When >1 lead was present, the maximum lead implant duration was used. §These groups are not mutually exclusive. Many subjects in this cohort had >1 indwelling implantable cardioverter-defibrillator lead and the presence of any singlecoil or dual coil-lead is reported here. Outcomes in Lead Abandonment Versus Explantation After matching, there were 24 908 patient encounters in the overall cohort matched 1:1 between abandonment and explantation; in the survival and 6-month complications Medicare cohorts, there were 1176 and 1042 patient encounters, respectively. Propensity score matching resulted in improved similarity between groups in all 3 analysis cohorts with the absolute standardized difference in all measured variables not >8% except for center explantation volume that remained poorly matched (Tables 1 and 2) . Notably, after matching in the overall cohort, lead implant duration averaged 5.7 and 5.6 years in the abandonment and explantation groups, respectively. In the matched Medicare survival and 6-month complication cohorts, lead implant duration was 4.5 and 4.4 years in the abandonment and explantation groups, respectively.
As noted above, we were not able to exclude those explantation procedures, involving simple traction techniques versus true extraction. However, only 7.2% of procedures in the overall cohort involved leads with a maximum lead implant duration of <1 year, and in many instances leads with a dwell time of ≥1 year are more likely to be removed with extraction.
In-Hospital Complications
In-hospital complications were evaluated in the 1:1 matched overall cohort. In the lead abandonment group, 286 (2.30%) patients experienced an intra or postprocedural event or death before discharge compared with 500 (4.01%) in the lead explantation group (P<0.001; Table 3 ). Compared with abandonment patients, explantation patients were more likely to die (26 [0.21%] versus 80 [0.64%] deaths, respectively; P<0.001) or to experience a complication before discharge (273 [2.19%] versus 469 [3.77%] events, respectively; P<0.001). When examined by type of event, explantation patients were more likely to experience cardiac arrest, cardiac perforation, cardiac valve injury, hematoma requiring intervention, hemothorax, infection requiring antibiotics, lead dislodgement, pericardial tamponade, peripheral embolus, venous obstruction, and urgent cardiac surgery (P≤0.02 for all; Table 3 ). There was no statistically significant difference in the rate of drug reaction, conduction block, coronary venous dissection, myocardial infarction, pneumothorax, set screw problem, or stroke/transient ischemic attack (P>0.05 for all), and the only complication that was numerically more common in the lead abandonment group was set screw problem (P=0.06). When examined by the severity of event, major complications were experienced by 103 patients (0.83%) in the lead abandonment group and 227 patients (1.82%) in the lead explantation group (P<0.001). Minor complications occurred in 166 (1.33%) and 262 (2.10%) patients, respectively (P≤0.001).
In a logistic regression model performed on the matched overall cohort, the odds ratio of an explantation patient experiencing an in-hospital complication or death compared with an abandonment patient was 1.73 (95% confidence interval, 1.53-1.95; P<0.001). This odds ratio was essentially unchanged after adjusting for demographic, medical history, procedural, hospital, and operator characteristics.
Mortality
Mortality risk was assessed in the 1:1 matched Medicare cohort. The mean follow-up was approximately 14.7 months in both the lead abandonment and explantation groups. There was numerically greater mortality in the explantation group compared with the abandonment group at each time point assessed: in-hospital, 90 days post discharge, and 1 year post discharge (Table 4 ). There were only 7 total in-hospital deaths in this cohort, including 2 in the abandonment group and 5 in the explantation group (P=0.26). Within 90 days of discharge, there were 19 (3.23%) and 24 (4.08%) deaths (P=0.44), and within 1 year, there were 48 (8.16%) and 67 (11.39%) deaths (P=0.06), respectively, in the lead abandonment and explantation groups ( Table 4 ). Allcause mortality is summarized with Kaplan-Meier survival curves in Figure 2 and demonstrates no statistically significant difference during the course of follow-up (P=0.16). 
Six-Month Complications
There were 1042 subjects enrolled in Medicare at the time of the procedure and for the subsequent 6 months that could be matched 1:1 to assess differences in six-month complications occurring after discharge between lead abandonment and explantation (Figure 1 ). There were no differences observed between groups in regard to bleeding, pericardial tamponade, infection requiring antibiotics, urgent surgery, upper extremity thrombosis, or pulmonary embolism at 6 months (P>0.05 for all; Table 5 ), although event rates were low for most of these outcomes.
Discussion
There are 3 major findings from our analysis of outcomes of patients undergoing lead revision of noninfected ICD leads from the NCDR ICD registry: first, procedural complications and death are low but occur slightly more frequently in patients undergoing explantation compared with abandonment. Second, in the Medicare subgroup, there was a trend toward greater mortality in the explantation group, but both groups had relatively high rates of 90-day and 1-year mortality with nearly 1 in 10 patients dead within a year. Finally, in Medicare patients, differences in complication rates including death in the year after hospital discharge were not statistically significantly different for patients undergoing lead explantation versus abandonment. Previous cohort studies and case series have found rates of periprocedural mortality from an unused or malfunctioning ICD lead extraction to be in the range of 0.3% to 0.6%. 10, 20 The in-hospital mortality rate in the overall cohort in our analysis was 0.64% in the explantation group and 0.21% in the abandonment group (P<0.001). In a Medicare subgroup, in-hospital mortality was 0.85% (explantation) and 0.34% (abandonment), but this was based on only 5 and 2 events, respectively (P=0.26).
Both the lead management strategies studied here were associated with low procedural risk with 2.19% of abandonment patients in the overall cohort experiencing an inhospital complication compared with 3.77% of explantation patients (P<0.001). This absolute difference of 1.58% corresponds to a number needed to harm of 63. It is noteworthy that the time period studied (2010-2011) was one in which the Medtronic Sprint Fidelis (Medtronic, Minneapolis, MN) recall was underway. Indeed, a majority of revised leads in our analysis were manufactured by Medtronic, and the majority of leads were revised in response to an advisory or recall (Data Supplement). Explantation of the Sprint Fidelis lead by experienced operators is generally considered to be less complicated than explantation of other leads (eg, Riata), 21 so the overall procedural risk observed in this cohort is likely conservative compared with contemporary experience. Moreover, actual or anticipated lead failures in the context of this recall may have encouraged lead revision of relatively young leads; average lead implant duration was approximately 5.5 years in all matched groups. Because lead implant duration is well known to correlate with lead explantation complications, this may also contribute to a conservative estimate of complications in the lead explantation cohorts. Tear of the superior vena cava is an important and potentially lethal complication of lead explantation, but it is not captured in the NCDR ICD Registry. Instead, urgent cardiac surgery is considered a reasonable surrogate. Therefore, it is intriguing that the number of in-hospital deaths in the explantation group (80) exceeded the number of urgent cardiac surgeries (59). This is consistent with evidence in the literature. 10, 22, 23 There are 3 potential explanations for this finding. First, explantation procedures taking place outside the cardiothoracic operating room complicated by a vascular tear or cardiac avulsion may result in death before urgent surgery can be undertaken. In this case, urgent cardiac surgery is considered a reasonable surrogate for vascular tear because the latter complication is not captured in the ICD Registry. Second, complications more common in the explantation group (eg, stroke) that do not require surgical intervention may contribute substantially to the mortality rate, and third, those complications occurring at similar rates in explantation and abandonment patients (eg, myocardial infarction) may be more deadly in explantation patients. As such, data on cause of death may help further explain this slight difference in mortality; however, these data are unavailable.
After discharge, all-cause mortality to 1 year in the Medicare cohort was slightly higher in the explantation group compared with the abandonment group (8.16 compared with 11.39%, respectively [P=0.06]). Although not statistically significant, the trend shows greater mortality in the explantation group with numerically more deaths at each time point measured (in hospital, 90 days post discharge, and 1 year post discharge). The Medicare subgroup was >10× smaller than the overall cohort, and as a result, had lower statistical power to identify mortality and safety differences between groups. However, the overall sample size represents the largest published cohort to date. Although the numeric difference in mortality between these groups of older patients seems to widen with increasing time (Figure 2) , it remains unknown how outcomes would differ beyond 1 year. Even if a difference exists in outcomes beyond 1 year, it is unclear how much of this difference is because of differences in comorbidities that could not be captured from observational data (when compared with a randomized trial).
In other investigations of outcomes after sterile lead extraction, mortality was lower. 10, 24, 25 For example, Maytin et al 25 reported outcomes of patients undergoing lead extraction at a single, high volume institution and found that among patients with extraction of sterile leads, 1-year mortality was 8.4%. However, our clinical practice cohort was older (mean, 75 years versus 56 years), had a higher burden of comorbid illness, especially diabetes mellitus, and had a greater range of center and provider volume that are known to make a difference in outcomes. 26, 27 The 1-year mortality rate for patients undergoing lead abandonment in this analysis was relatively high, despite low rates of ICD-related complications (Table 4 ). Interestingly, this mortality rate and the mortality rate in the explantation group are similar to that seen in an all-comer NCDR ICD Registry cohort undergoing elective generator replacement in which a 9.8% 1-year mortality was observed and only 6.2% of subjects underwent concomitant lead revision. 28 This suggests that in clinical practice, lead revision decisions are often made in older patients with multiple comorbidities such that the risk of any procedure increases with increasing comorbidity burden and competing risks of death. Indeed, choosing a revision strategy involves complex decision making. For example, in our prematched cohorts, maximum lead implant duration was significantly longer in abandonment patients compared with explantation patients that likely reflects healthcare providers' awareness that longer implant duration increases the risks of explantation. Although this difference was balanced with propensity matching, other differences between groups may be less well captured in the Registry.
To assess outcomes beyond the index hospitalization, we had to limit our cohort to those patients enrolled in Medicare. In this subgroup, we assessed complications within 6 months of hospital discharge and found no difference between the explantation and abandonment groups for any outcome. This means that although there were differences in the overall cohort between groups in regard to infection, tamponade, venous obstruction, and urgent surgery before discharge, there were no differences seen at 6 months in these outcomes in the Medicare subgroup. Notably, complications from lead abandonment are more difficult to capture than those from explantation, especially from claims data in which some outcomes (eg, asymptomatic venous occlusion) may not be captured. Moreover, whether they are captured in claims data or not, complications from lead abandonment may be expected to accrue over a much longer time period than 1 year. Thus, longer-term complications of abandonment may be more relevant in a younger cohort in whom leads that may someday need extraction are left to dwell longer as comorbidities and age accumulate. On the basis of these results, and consistent with previous work, although lead explantation is a riskier procedure in the short term, both lead explantation and lead abandonment are associated with relatively few deaths and complications. At 1 year, explantation does not seem to provide benefit over lead abandonment in a Medicare population.
Limitations
The decision to explant or abandon an unused or malfunctioning ICD lead involves numerous considerations many of which are not included in our analysis: perceived surgical risk, life expectancy, and patient preferences to name a few. In addition, outcomes in our analysis were limited to those in the ICD Registry and in the Centers for Medicare and Medicaid Services administrative database; other outcomes (eg, asymptomatic venous occlusion), intermediate-term outcomes in non-Medicare patients, and outcomes outside of the 2010 to 2011 window during which the Sprint Fidelis lead recall was underway were not available, and so our results may not apply to all patients or more current procedures or leads. We used propensity score matching by including an extensive list of clinically relevant variables to reduce the bias of healthier patients undergoing lead explantation; this process leaves some patients unmatched, so our results may not apply to patients with the highest level of comorbidity burden or other outlier characteristics. In particular, we were unable to match well on the variable of center explantation volume (absolute standard difference >60%) such that patients undergoing explantation were treated in centers with a much greater average number of explants per year, which has 2 potential implications: (1) these findings may underestimate complication rates at centers with lower explantation volume and (2) this may represent a referral bias; patients undergoing explantation may have more commonly been referred to an explantation center specifically for explantation making their revision strategy "predetermined". In addition, propensity score matching cannot account for every clinical scenario, so the differences in outcomes between lead abandonment and lead explantation patients in our analysis may not apply to all propensity-matchable patients. For example, although we matched patients based on long-term warfarin usage to account for risks of procedural bleeding, this does not take into account how perceived risks of warfarin discontinuation influenced lead revision decisions, and although procedural bleeds associated with warfarin continuation through a procedure would be well captured in this analysis, embolic strokes occurring after discharge would not be. Finally, we could not exclude explantation procedures involving simple traction techniques versus true extraction. Although the number of procedures (7.2%) involving leads with the dwell time of <1 year is too small to have a large impact on the overall outcomes, it should be acknowledged that some leads with the dwell time of ≥1 year can be removed with simple traction, and as a result, 7.2% likely underestimates the true number of leads that were removed with simple traction.
Clinical Implications
In this study, management of unused or malfunctioning ICD leads was associated with <1% in-hospital mortality and <5% overall in-hospital complications regardless of the adopted strategy. After hospitalization for lead management, mortality was somewhat higher at discharge, 90 days, and 1 year among Medicare-aged patients undergoing explantation versus abandonment, but 6-month device-related complications seemed to be similar between the 2 groups. Future longitudinal studies will hopefully provide better understanding of the longer-term outcomes of lead abandonment and explantation, especially in younger patients. However, only adequately powered randomized prospective trials with long-term follow-up can provide the most meaningful guidance to patients and physicians facing the decision to abandon or explant an unused or malfunctioning lead.
